Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani
Research To Practice | Oncology Videos · Dr. Neil Love
February 6, 202546m 31s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring an interview with Dr Saad Zafar Usmani, including the following topics:
- Optimizing treatment intervention for patients with newly diagnosed multiple myeloma (MM) (0:00)
- Role of anti-CD38 antibodies in induction and maintenance therapy for patients with newly diagnosed disease (4:22)
- Case: A woman in her late 70s with revised International Staging System (R-ISS) Stage II IgG kappa myeloma who received D-Rd followed by maintenance daratumumab (14:02)
- Case: A man in his early 60s with double-hit myeloma who received D-KRd and carfilzomib maintenance therapy (26:10)
- Case: A man in his early 70s with R-ISS Stage III IgG kappa myeloma and translocation (4;14) who deferred transplant (33:24)
- Future directions in the management of MM (40:37)
CME information and select publications